@article{Glancy_M-2024_179382,
title = {Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study},
author = {Glancy, M. and Yeung, A. and McAuley, A. and Palmateer, N. and Bishop, J. and Taylor, B. and Lang, J. and Barnsdale, L. and Priyadarshi, S. and Hutchinson, S.},
month = {jun},
year = {2024},
abstract = {ObjectivesAmong people receiving opioid-agonist treatment (OAT), the risk of COVID-19 infection and disease may be higher owing to underlying health problems and vulnerable social circumstances. We aimed to determine whether recent OAT, compared to past exposure, affected risk of (i) testing for SARS-CoV-2, (ii) testing positive for SARS-CoV-2 and (iii) being hospitalized/dying with COVID-19 disease.},
journal = {Clinical Microbiology and Infection},
publisher = {Elsevier},
url = {https://doi.org/10.1016/j.cmi.2024.06.019},
}
